Modify Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Modify Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Modify Therapeutics Today - Breaking & Trending Today

Triveni Bio Launches with $92 Million Series A Financing to Advance Genetics-Informed Precision Medicines for the Treatment of Immunological and Inflammatory (I&I) Disorders

Published: October 26, 2023

/PRNewswire/ -- Triveni Bio Inc., a biotech company pioneering a genetics-informed precision medicine approach to develop functional antibodies for the...

Source: prnewswire.com

Related Topics:

Al IskandariyahJennifer DoveyVishal PatelTillman GerngrossLeonard ZonTriveni BioRaymond KelleherPrnewswire Triveni Bio IncAtlas VentureBio IncCormorant Asset ManagementViking Global InvestorsPolaris PartnersAlexandria Venture InvestmentsChief Scientific OfficerChief ExecutiveAmagma TherapeuticsModify TherapeuticsBoard ChairManaging Director

Triveni Bio Raises $92M in Series A

Published: October 26, 2023

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Source: finsmes.com

Related Topics:

Al IskandariyahJennifer DoveyLeonard ZonTriveni BioTillman GerngrossVishal PatelAtlas VentureCormorant Asset ManagementViking Global InvestorsPolaris PartnersAlexandria Venture InvestmentsChief Scientific Officer Jennifer DoveyAmagma TherapeuticsModify Therapeutics

Triveni emerges from biotech merger with $92M for immune disease drugs

Published: October 26, 2023

BioPharma

Source: biopharmadive.com

Related Topics:

United StatesAl IskandariyahTriveni BioAmgen EnbrelNicholas ScarchilliVishal PatelJennifer DoveyAbbvie HumiraTillman GerngrossAbbvie RinvoqBristol Myers Squibb SotyktuVanderbilt University Medical CenterAtlas VentureDive BriefAmagma TherapeuticsModify TherapeuticsCormorant AssetBristol Myers SquibbNashville BiosciencesVanderbilt University MedicalViking Global InvestorsPolaris PartnersAlexandria Venture Investments